ArticleDermatologic therapy2021

Drug survival of ixekizumab, TNF inhibitors, and other IL-17 inhibitors in real-world patients with psoriasis: The Corrona Psoriasis Registry.

Benjamin Lockshin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.